Buscar

Mostrando ítems 1-10 de 104

Interleukin-6 deficiency influences cytokine expression in susceptible BALB mice infected with Leishmania major but does not alter the outcome of disease.

Titus, Richard G; Dekrey, Gregory K; Morris, Robin V; Soares, Milena Botelho Pereira (American Society for Microbiology, 2015)

Vaccines in leishmaniasis: advances in the last five years

Brodskyn, Claudia Ida; Oliveira, Camila Indiani de; Barral, Aldina Maria Prado; Barral Netto, Manoel (Future Drugs LTD, 2014)

Challenges and perspectives in vaccination against leishmaniasis.

Oliveira, Camila Indiani de; Nascimento, Ivan Pereira; Barral, Aldina Maria Prado; Soto, Manuel; Barral Netto, Manoel (Elsevier Ireland Ltd., 2014)

BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge

Ramírez, Laura; Iborra, Salvador; Cortés, Jimena; Bonay, Pedro; Alonso, Carlos; Barral Netto, Manoel; Soto, Manuel (Hindawi Publishing Corporation, 2014)

Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment

Reis, Luiza C.; Brito, Maria Edilenza F.; Souza, Marina A.; Medeiros, Angela C. R.; Silva, Claudio J.; Luna, Carlos F.; Pereira, Valéria R. A. (2018)

Antigenic fractions of Leishmania (Viannia) braziliensis: the immune response characterization of patients at the initial phase of disease

Brelaz, M. C. A.; Oliveira, A. P. de; Almeida, A. F. de; Souza, M. de Assis; Medeiros, Â. C. R.; Brito, M. E. F. de; Pereira, V. R. A. (2018)

Sub-clinical infection as an effective protocol for obtaining anti-Leishmania chagasi amastigote antibodies of different animal species

Fróes, Adriana M.; Santos, Cláudia V. D. dos; Penha Filho, Manoel Leoncio da; Teixeira, Márcia Cristina Aquino; Silva, Tânia Maria Correia; Oliveira, Geraldo Gileno de Sá; dosSantos, Washington Luis Conrado; Pontes-de-Carvalho, Lain Carlos; Neves, Neuza Maria Alcântara (Elsevier, 2014)

Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis.

Ramirez, Laura Garcia; Corvo, Laura; Duarte, Mariana Costa; Fumagalli, Miguel Angel Chávez; Valadares, Diogo Garcia; Santos, Diego Moura; Oliveira, Camila Indiani de; Escutia, Marta R; Alonso, Carlos; Bonay, Pedro; Tavares, Carlos Alberto Pereira; Coelho, Eduardo Antonio Ferraz; Soto, Manuel (BioMed Central, 2015)

Th1/Th2 cytokine profile in patients coinfected with HIV and Leishmania in Brazil.

Rodrigues, Maria Zilma Andrade; Grassi, Maria Fernanda Rios; Mehta, Sanjay; Zhang, Xing-Quan; Gois, Luana Leandro; Schooley, Robert T; Badaró, Roberto José da Silva (American Society for Microbiology, 2014)

Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis.

Garcia, Laura Ramírez; Santos, Diego Moura; Souza, Ana Paula Almeida de; Coelho, Eduardo Antonio Ferraz; Barral, Aldina Maria Prado; Alonso, Carlos; Escutia, Marta R; Bonay, Pedro; Oliveira, Camila Indiani de; Alvarez, Manuel Soto (Elsevier Ltd, 2014)

1
2
3
4
. . .
11